Why NovoCure Ltd (NVCR) Stock Is Rising
As of 2026-07-27, NovoCure Ltd (NVCR) has a next-year EPS growth estimate of 38.16%. Featured in our EPS revision report on 2026-07-27.
Why NVCR Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised NovoCure Ltd's next-year EPS growth estimate from 33.29% to 33.58% on 2026-07-22.
- →Estimate Trending Higher: Since detection, the estimate has moved up a net +4.58 pp to 38.16% across 2 upward revisions.
- !Largest Single-Day Revision: +3.48 pp on 2026-07-24 (34.70% → 38.18%).
- ·Current-Year Growth: Projected at -6.31%, supporting the forward estimate revision.
News Context
The primary structural driver for NVCR’s rise is a series of EPS estimate upgrades, with the next-year growth estimate increasing from 33.29% to 38.16% across multiple revisions. This was catalyzed by the Q2 2026 earnings beat, which featured record revenue and an upwardly revised 2026 outlook due to Optune expansion. The stock continued to gain momentum after the initial revision, surging 28% and hitting a 52-week high as analysts raised estimates further.
Generated 2026-07-27 · news as of 2026-07-27
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 38.16%
- EPS growth this year
- -6.31%
- EPS next quarter (est)
- -$0.25
- Last price
- $17.37
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-27 | 38.16% | -6.31% | -$0.25 | $17.37 |
| 2026-07-26 | 38.16% | -6.31% | -$0.25 | $17.65 |
| 2026-07-24 | 38.18% | -6.28% | -$0.25 | $17.65 |
| 2026-07-23 | 34.70% | -15.21% | -$0.28 | $19.99 |
| 2026-07-22 | 33.58% | -28.52% | -$0.33 | $15.57 |
| 2026-07-21 | 33.29% | -30.08% | -$0.33 | $16.00 |
| 2026-07-20 | 33.29% | -30.08% | -$0.33 | $15.94 |
| 2026-07-19 | 33.29% | -30.08% | -$0.33 | $15.92 |
| 2026-07-17 | 33.29% | -30.08% | -$0.33 | $15.92 |
| 2026-07-16 | 33.29% | -30.08% | -$0.33 | $16.42 |
| 2026-07-15 | 33.29% | -30.08% | -$0.33 | $16.03 |
| 2026-07-14 | 33.29% | -30.08% | -$0.33 | $15.55 |
| 2026-07-13 | 33.29% | -30.08% | -$0.33 | $16.09 |
| 2026-07-12 | 25.20% | -30.64% | -$0.33 | $16.30 |
| 2026-07-09 | 25.20% | -30.64% | -$0.33 | $17.29 |
| 2026-07-08 | 25.20% | -30.64% | -$0.33 | $17.37 |
| 2026-07-07 | 25.20% | -30.64% | -$0.33 | $17.72 |
| 2026-07-06 | 25.20% | -30.64% | -$0.33 | $17.32 |
| 2026-07-05 | 25.20% | -30.64% | -$0.33 | $17.20 |
| 2026-07-02 | 25.20% | -30.64% | -$0.33 | $17.20 |
| 2026-07-01 | 25.20% | -30.64% | -$0.33 | $15.78 |
| 2026-06-30 | 25.20% | -30.64% | -$0.33 | $15.15 |
| 2026-06-29 | 25.20% | -30.64% | -$0.33 | $15.48 |
| 2026-06-28 | 25.20% | -30.64% | -$0.33 | $15.43 |
| 2026-06-25 | 25.20% | -30.64% | -$0.33 | $15.05 |
| 2026-06-24 | 25.20% | -30.64% | -$0.33 | $14.72 |
| 2026-06-23 | 25.20% | -30.64% | -$0.33 | $14.13 |
| 2026-06-22 | 25.20% | -30.64% | -$0.33 | $13.61 |
| 2026-06-21 | 25.20% | -30.64% | -$0.33 | $14.28 |
| 2026-06-18 | 25.24% | -30.64% | -$0.33 | $14.28 |
Reports Featuring NVCR
Recent News
- Why Did CSX, UNP, NVCR Stocks Surge To 52-Week Highs Today?Stocktwits
- NVCR Stock Surges 28% For Best Day In Over 1.5 Years Whats Driving The Rally?Stocktwits
- NVCR Stock Surges 28% For Best Day In Over 1.5 Years Whats Driving The Rally?Stocktwits
- NovoCure Ltd (NVCR) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...GuruFocus.com
- NovoCure Ltd (NVCR) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...GuruFocus.com
- Novocure Reports Record Second-Quarter Revenue as Optune Expansion Drives Higher 2026 OutlookInvestorsHub
- Novocure Reports Record Second-Quarter Revenue as Optune Expansion Drives Higher 2026 OutlookInvestorsHub
- Novocure Flashes A Bullish Signal As It Breaks Out; Have Shares 'Turned A Corner?'Investor's Business Daily
- Novocure Flashes A Bullish Signal As It Breaks Out; Have Shares 'Turned A Corner?'Investor's Business Daily
- NovoCure: Q2 Earnings SnapshotAssociated Press
Screen Performance
Aggregate stats across all 1885 tickers our top-EPS-revision screen has flagged over the past 117 days.
- Median return since detection
- +1.8%
- % of tickers in the green
- 54%
- Median return on winners
- +19.0%
- Large revisions captured
- 1123
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did NovoCure Ltd (NVCR) stock go up recently?▾
NovoCure Ltd (NVCR) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 33.29% to 33.58% on 2026-07-22. Since detection, the estimate has moved up a net +4.58 pp to 38.16%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is NovoCure Ltd's next-year EPS growth estimate?▾
As of 2026-07-27, NovoCure Ltd (NVCR) has a next-year EPS growth estimate of 38.16%, based on analyst consensus.
When was the latest EPS estimate revision for NVCR?▾
The most recent revision occurred on 2026-07-26, when analysts adjusted the next-year EPS growth estimate from 38.18% to 38.16%.
What sector and industry does NovoCure Ltd belong to?▾
NovoCure Ltd operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NVCR appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. NovoCure Ltd (NVCR) appears here because it was detected by our daily top-EPS-revision-performer screen.